Benzinga  Apr 29  Comment 
Biocept, Inc. (Nasdaq: BIOC) revealed it has priced its public offering of approximately 5.0 million shares at a price of $1.00 per share to the public. According to the company, investors will also get warrants to purchase a maximum of about 3.5...
newratings.com  Jul 15  Comment 
SUMMIT (dpa-AFX) - Shares of Aratana Therapeutics Inc. (PETX) were up more than 7% in after-hours trading on Tuesday, following positive results from its pivotal field effectiveness study of AT-003, the company's innovative drug for treating...
TheStreet.com  Jul 14  Comment 
NEW YORK (TheStreet) -- Biocept shares are up by 6.06% to $2.80 in afternoon trading on Tuesday, after the cancer diagnostics company announced the launch of its proprietary, quantitative assay targeting BRAF mutations.The test,...
TheStreet.com  Jul 1  Comment 
NEW YORK (TheStreet) -- Biocept  shares are rallying 6.67% to $2.72 on heavy trading volume after the company said today that it is expanding its blood-based test menu to identify key biomarker for breast and lung cancer. Biocept is a...
TheStreet.com  Feb 10  Comment 
NEW YORK (TheStreet) -- Shares of Biocept plummeted 36.46% to $1.15 on heavy trading volume this afternoon following the molecular oncology diagnostics company's announcement late yesterday of the pricing of 8 million shares of its common...
StreetInsider.com  Oct 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biocept+%28BIOC%29%2C+Rosetta+Genomics+%28ROSG%29+Enter+Cancer+Diagnostics+Collaboration/9905038.html for the full story.
newratings.com  Jun 3  Comment 
INDIANAPOLIS (dpa-AFX) - Aquinox Pharmaceuticals Inc. (AQXP) is expanding its ongoing phase II clinical trials with its lead product candidate, AQX-1125. Accordingly, the company's phase II trial of AQX-1125 in reducing pain and urinary...
StreetInsider.com  Feb 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/JLL+Partners+Begins+%247.25Share+Tender+for+BioClinica+%28BIOC%29/8077229.html for the full story.
StreetInsider.com  Sep 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioClinica%27s+%28BIOC%29+OnPoint+Selected+for+Use+By+Sanofi+%28SNY%29+as+CTMS+Standard/7744845.html for the full story.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki